Pharma & Biotech
-
With 11th Deal in Last Three Years, Radnor’s VWR Makes Yet Another Acquisition
Radnor’s VWR has acquired MESM, the global provider of laboratory and medical equipment and ancillary supplies to clinical trials, as part of its ongoing growth strategy, writes John George for the Philadelphia Business Journal. This marks the third deal for VWR this year, and the 11th over the last three years. “MESM is recognized and…
-
Clinical Trial Company with Office in Wayne Acquired by Private Equity Firm
Bracket, the clinical trial technology and specialty services provider with offices in Wayne, has been acquired by private equity firm Genstar Capital, writes John George for the Philadelphia Business Journal. San Francisco’s Genstar Capital purchased Bracket from Parthenon Capital Partners, which has owned the company for the last four years. The company has more than…
-
Radnor’s VWR Acquires Critical Storage for Its Lab Products
With 10 acquisitions in three years, Radnor-based VWR apparently needed space to put all of its new business, and this week’s buyout of EPL Archives provides 190,000 square feet for biostorage, according to a Philadelphia Business Journal report by John George. VWR has rapidly grown its portfolio of research lab products to more than 1.2…
-
Chester’s PharmaTouch Launches Restructured Brand, Revamped Website
Chester’s PharmaTouch has restructured its brand and launched a new website as part of its evolution into a customer-first provider for the pharma, biotech, healthcare, and animal sciences industries. The new brand focuses on a number of new solutions based on the PharmaTouch CoreTouch Cloud Platform. This software as a service product includes sophisticated tools…
-
As ‘Conscience of the Profession,’ Newtown Square Pharmacist Claims Industry’s Highest Honor
Over the course of 51 years, he has influenced more than 10,000 pharmacy students, stayed at the cutting edge of an evolving pharmaceutical industry, navigated ongoing ethics twists and turns, advocated for patients, and boldly confronted controversial issues. In return, a grateful American Pharmacists Association will reward Daniel A. Hussar’s life of service with its…
-
Radnor’s VWR Acquires Canadian Manufacturer of Reagents for Chemical Analysis
Radnor’s VWR, a leading independent provider of product and service solutions to laboratory and production customers across the world, has acquired Seastar Chemicals, a Canadian manufacturer of high purity reagents used in the global research, laboratory, and microelectronics industries. Seastar is a global leader in quality in production of ultra-pure acid and base products that…
-
Greater Philly a Premier Breeding Ground for Life Sciences, Per Its $25 Billion Footprint
With its dozen-plus world-renowned research institutions and top biomedical programs, a healthy ecosystem of 1,200 small and large enterprises employing nearly 50,000 people, and $6.3 billion of investment activity, Greater Philadelphia is a breeding ground for life sciences innovation and leadership. That’s according to the new Greater Philadelphia Life Sciences Report, jointly put together by…
-
Radnor Pharma Company Gets Head Start on Treating Fragile X in Children
Marinus Pharmaceuticals in Radnor is getting a jumpstart over the competition in the race to develop a treatment for the rare, autism-like Fragile X Syndrome found in children. The U.S. Food and Drug Administration’s recently awarded orphan drug designation gives Marinus the exclusive opportunity to market a product over the next seven years, along with…
-
Radnor’s VWR Named One of Nation’s 100 Healthiest Workplaces
The dedication to its employees’ wellbeing has paid off for Radnor’s VWR, as the company has been recognized by Springbuk as a 2016 Healthiest 100 Workplace in America. Applicants for the award were evaluated across six key categories, including vision and expertise. The winning organizations combine a number of employee wellness initiatives, alongside corporate wellness…
-
Local Police Firing New Weapon in War Against Drugs
Unlike some of the area’s pharmaceutical heavyweights, the office complex of Adapt Pharma in Radnor is barely noticeable. But its only product packs quite a punch. In the year since Adapt’s “antidote” for heroin overdoses, NARCAN Nasal Spray, was approved by the Food and Drug Administration, it has unassumingly put itself on the national scene,…
-
Radnor’s VWR Foundation Distributes Six Figures in Grants in October
The VWR Foundation, based in Radnor, awarded more than $115,000 in grants to 13 recipients during its October meeting. The foundation, dedicated to giving back to the science community, supports organizations and programs that align with its three main, strategic priorities of research, health and well-being, and science education. One of the recipients is Norwich…
-
Radnor’s VWR Scoops Up Two More Competitors
Radnor’s VWR, the international laboratory equipment supplier, has acquired two of its smaller competitors, reaffirming its growth-through-acquisition approach, writes John George for the Philadelphia Business Journal. The company has purchased BioArra and Reliable Biopharmaceutical, which brings the total number of companies it has acquired over the last two years to eight. BioArra, which was founded…
-
Two Delco High Schools to Receive Opioid Overdose Spray from Radnor’s Adapt Pharma
Adapt Pharma, which has its U.S. headquarters in Radnor, is donating two doses of its Narcan Nasal Spray treatment for opioid overdoses to 128 high schools across the state, including a pair in Delaware County, writes Alison Burdo for the Philadelphia Business Journal. The Ridley School District and Penncrest High School will receive the medication…
-
Opioid Overdose Drug of Radnor’s Adapt Pharma to Become Available in Canada
Radnor’s Adapt Pharma has been granted approval by Health Canada to make its nasal spray used to treat opioid overdoses available there, writes John George for the Philadelphia Business Journal. The Canadian agency recently gave the green light for Adapt’s naloxone hydrochloride nasal spray to be used in emergency situations outside of a hospital to…
-
If Lab-Products Industry Were Like the Game of Risk, Radnor’s VWR Would Be Dominating
Radnor-based laboratory products and equipment supplier VWR is maintaining its “growth by acquisition” strategy by making its sixth purchase in less than two years, writes John George for the Philadelphia Business Journal. VWR has acquired PAW BioSciences Products, a manufacturer and distributor of products for sanitary-fluid handling used in the biotechnology, biopharmaceutical, and diagnostic industries.…
-
U.S. Rep. Patrick Meehan Visits Narcan Manufacturer in Radnor Before Opioids Conference
Days before starting work on the Opioids Conference Committee, U.S. Representative Patrick Meehan took the time to visit Radnor’s manufacturer of Narcan, the nasal spray that revives people overdosing on opioids, writes Kathleen Carey for the Daily Local News. While naloxone has been in use for more than four decades, Adapt Pharma, founded only three years…
-
Radnor Woman Among First Patients in America to Receive New Treatment for Opioid Addiction
Local sufferers of opiate addition in long-term recovery programs are among the first in the country to gain access to a newly approved treatment option, according to a staff report from 6ABC. Last month, the FDA approved Probuphine, a new implant type treatment for battling addiction. Among the first patients to receive the treatment was…
-
Radnor’s Adapt Pharma Finds Partner for Delivery System of Its Signature Nasal Spray Used to Treat Opioid Overdoses
Radnor’s Adapt Pharma, maker of the Narcan Nasal Spray used for the emergency treatment of opioid overdose, has partnered with Aptar Pharma, a leader in the global dispensing systems industry, to provide Narcan’s delivery system and regulatory support. According to Jim Butschli, editor of Healthcare Packaging, Aptar Pharma referred to Narcan as “the first U.S.…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
